Seeing Is Believing
Sunesis Pharmaceuticals's activity chart (see below) currently has 2 price targets and 3 ratings on display.
Analysts average stock forecasts to be materialized ratio is 71.43% with an average time for these price targets to be met of 274.71 days.
Most recent stock forecast was given by from OPPENHEIMER on 23-Feb-2021. First documented stock forecast 11-Jun-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Mar-2019
$12
$-1.28 (-9.64%)
5 years 4 months 21 days ago
(23-Feb-2021)
1/2 (50%)
$-2.98 (-19.89%)
544
Hold Since 11-Mar-2020
$10
6 years 2 months 6 days ago
(08-May-2020)
1/1 (100%)
$-12.05 (-54.65%)
107
Buy Since 11-Dec-2017
$10
$-3.28 (-24.70%)
$80
6 years 4 months 3 days ago
(11-Mar-2020)
3/3 (100%)
$-12.05 (-54.65%)
200
Hold Since 02-May-2017
$30
$16.72 (125.90%)
$50
8 years 7 months 9 days ago
(05-Dec-2017)
2/2 (100%)
$-53.65 (-64.14%)
449
Buy
$360
$346.72 (2610.84%)
10 years 11 months 20 days ago
(24-Jul-2015)
0/1 (0%)
$158.61 (78.76%)
What is SNSS (Sunesis Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on SNSS (Sunesis Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on SNSS (Sunesis Pharmaceuticals)?
Which analyst is the currently most bullish on SNSS (Sunesis Pharmaceuticals)?
Which analyst is the currently most reserved on SNSS (Sunesis Pharmaceuticals)?